Interestingly, DARPP-32 overexpression has a pro-cancer activity in colorectal cancer [38], non-small cell lung carcinoma [39], gastric cancer [40] and has even been discussed as a potential anti-cancer target [41]. This evidence concerns the gene PPP1R1B and cancer.